Number of patients 63 Age at treatment onset; mean ± SD, range (years) 10.5 ± 4.3, 0.5–17.5 Gender; males/females 36/27 Etiology, number of patients Idiopathic factors 45 (71.4 %) Toxic exposure 6 (9.5 %) Seronegative hepatitis…
Sociodemographic and behavioral variables Non-carriers of N. meningitidis (n = 527) Carriers of N. meningitidis (n = 32) p Age Mean ± SD 30.2 ± 4.8 29.3 ± 4.4 0.407 Range 21.0–52.0 22.0–43.0 Median 29.0 29.0 95 % CI 29.8–30.6 27.7–30.9…
Hemodialyzed (n = 55) Healthy (n = 55) R NR R NR A/H1N1 65 35 95 5 A/H3N2 89 11 89 11 B 80 20 75 25 Data are % of subjects Further…
, A. Nitsch-Osuch2, K. Preisner1 and L. Szenborn1 (1) Department of Pediatric Infectious Diseases, Medical University of Wrocław, 44 Bujwida St., Wroclaw, Poland (2) Department of Family Medicine, Warsaw Medical University, Warsaw, Poland…
Fig. 1 Infections caused by influenza and influenza-like viruses causing respiratory disease in Poland in 2010–2011 epidemic season; investigated within the I-MOVE project The results show that influenza and other…
Fig. 1 Data from respondents concerning the presumed number of annual deaths from influenza and its complications worldwide (Panel A), the vaccine-related protection of pregnant women (Panel B), and young…
© Springer International Publishing Switzerland 2014Mieczyslaw Pokorski (ed.)Respiratory Virology and ImmunogenicityAdvances in Experimental Medicine and Biology83610.1007/5584_2014_12 Reactive Oxygen Species, Granulocytes, and NETosis Magdalena Araźna1 , Michał P. Pruchniak1 and Urszula Demkow1 (1) Department of Laboratory Diagnostics and Clinical…
Antigen Group Current vaccination GMT Unvaccinated previously (A1, B1) Vaccinated in previous seasons (A2, B2) p A/Brisbane/59/2007 (H1N1) A Before 1.3 A1 2.0 A2 0.27 After 19.1 A1 11.6 A2…
